Key result
Total coronary blood flow was lower in patients with coronary heart disease and noncoronary heart disease compared to normal subjects.
Why the study?
Does total and effective coronary blood flow differ between normal subjects, patients with coronary heart disease, and patients with noncoronary heart disease?
Cross-Sectional (n=54)
No
Does total and effective coronary blood flow differ between normal subjects, patients with coronary heart disease, and patients with noncoronary heart disease?
Answers are grounded in this paper and cite their sources.
Total and effective coronary blood flow are significantly reduced in patients with coronary and noncoronary heart disease compared to normal subjects, with a significant discrepancy between total and effective flow in diseased states.
There are no data available concerning total coronary blood flow to the whole heart (CBF) in man. "Effective" or "nutrient" coronary blood flow to the whole heart (MBF), supposedly a measure of flow through exchanging channels of the coronary circulation, has been measured but its validity has not been established. Accordingly, CBF and MBF were measured in 9 normal subjects, 26 patients with coronary heart disease (CHD), and 19 with noncoronary, mostly valvular heart disease (NCHD), by coincidence counting 84Rb technique. Two methods were used: single bolus (24 cases) and continuous infusion (30 cases). Various other parameters including myocardial oxygen utilization (MVO2) and lactate extraction ratio were determined. In the normal subjects CBF (386 +/- 77 ml/min) was significantly higher (P < 0.05) than in CHD (288 +/- 124 ml/min) and NCHD (292 +/- 111 ml/min). Likewise the normal MBF (380 +/- 81 ml/min) was significantly higher (P < 0.01) than in CHD (251 +/- 105 ml/min) as well as NCHD (258 +/- 104 ml/min). The myocardial Rb extraction ratio epsilon Rb) was significantly lower in normal subjects (39 +/- 9%) than in CHD (50 +/- 7%) and NCHD (52 +/- 11%) and this supports the view that epsilon Rb is flow-dependent. In both CHD and NCHD there was significant diminution of MVO2 as well as CBF. In CHD this was accompanied by a significant anaerobic trend but in NCHD it was not. It might therefore appear that in CHD, MVO2 is determined by perfusion whereas in NCHD, perfusion is determined by MVO2. In comparing CBF with MBF by paired observation testing, there was no significant difference in the normals (P > 0.3), whereas the differences were significant in CHD (P < 0.01) and NCHD (P < 0.02). This was merely a reflection of a reduced ratio of myocardial to total body epsilon Rb in CHD and NCHD, and available evidence indicates that this may be an expression of depressed transport of Rb+ rather than true shunting.
No takes yet. Share an insight, caveat, or question.
Mymin et al. (1974) conducted a cross-sectional in Coronary and noncoronary heart disease (n=54). Coronary heart disease and noncoronary heart disease vs. Normal subjects was evaluated on Total coronary blood flow (CBF) (p=<0.05). Total coronary blood flow was lower in patients with coronary heart disease and noncoronary heart disease compared to normal subjects.
Synapse has enriched 10 related papers. Consider them for comparative context: